The Challenge
MediBot had developed a groundbreaking AI-powered diagnostic tool but faced significant hurdles in navigating India's complex medical device regulations. The uncertainty around compliance was a major red flag for potential investors.
The Solution
Our regulatory experts created a clear roadmap for achieving compliance with the CDSCO. We assisted in preparing the necessary documentation and built a financial model that incorporated the costs and timelines of clinical trials and regulatory approvals. This provided a clear, credible plan for investors.